AAAS CEO Alan I. Leshner statement on the UN clon...( Washington DC -- A statement from Dr. ...)

AAAS CEO Alan I. Leshner statement on the UN cloning debate

Washington, DC -- A statement from Dr. Alan I. Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science, on the debate over research cloning that is scheduled to begin at the United Nations on Thursday 21 October 2004:

"We realize that this issue generates intense debate. We have long opposed human cloning to produce babies as dangerous and irresponsible. But we believe that nuclear cell transplantation research - what is called research or therapeutic cloning - holds the potential to ease tremendous suffering and prolong life for countless millions of people. For that reason, this window of scientific and eventual clinical opportunity should not be shut prematurely.

"These positions are reflected in the measure sponsored by Belgium-a measure that clearly represents the mainstream of scientific and medical thinking in the United States and worldwide."

'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
20-Oct-2004

Post Your Comments:

(Date:11/24/2009)...opening new doors to understanding how sounds asso... a marine mammal or if they hear it at all. , T...ers that NASA uses to detect flaws in the space sh...g scientists to peek inside the giant head of a wh...ional replicas of a whale,s hearing anatomy using ...

(Date:11/24/2009)...eakened and flabby arteries from collapsing have b...stents are no longer needed -- once the arteries a...ly, doctors had no choice but to leave them in pla...ity,s Department of Biomedical Engineering has dev...rries drugs where they,re needed, then dissolves. ...

(Date:11/24/2009)...merican College of Medical Toxicology (ACMT) have ...ion of the Journal of Medical Toxicology (JMT), ...ch 2010. It was previously published by the Unive...Medical Toxicology , an international, peer-review...and practice of medical toxicology. The quarterly...

Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2 A coating for life 2 Springer and the American College of Medical Toxicology to work together 2 New collaborative center to provide education research on temperate rainforests 9600 1 New collaborative center to provide education research on temperate rainforests 9600 2 Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 1 Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 2 Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 3 Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 4 Hurricane Season Heats Up 54655 1 Hurricane Season Heats Up 54655 2 Hurricane Season Heats Up 54655 3

[1] Rocket science leads to new whale discovery [0] A coating for life [1] Springer and the American College of Medical Toxicology to work together

(Date:11/24/2009)...eMarbleEnergyCorp.announcedtodaythatthecompanyandt...lyawarded$2millionbyWashingtonState,sCommunityEcon...nershiptoconstructthestate,sfirstspecialtybiochemi...tmentwillsignificantlyspeedthedevelopmentofourbior...dBlueMarbleEnergyCEOKellyOgilvie."Wearegratefultot...

(Date:11/24/2009)...etforpatientswithadvanced-stage,orrecurrentendomet...rstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ...usedonendocrinetherapyandoncology,todayannouncedpo...ytotoxicpeptideconjugate,AEZS-108(formerlyAN-152),....Inapersonalizedhealthcareapproach,thestudyselecte...

(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...

(Date:11/24/2009)...swire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX ...tiveChairman,willpresentatthe21stAnnualPiperJaffra...er1,2009at10:00a.m.ET. ,, Toaccesstheliveandsub...InvestorRelationssectionofGenomicHealth,swebsiteat...othewebsiteatleast15minutespriortothebeginningofth...

Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3 Genomic Health to Present at Piper Jaffray Health Care Conference 2

[0] Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board [0] AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease [0] Genomic Health to Present at Piper Jaffray Health Care Conference

Other News:

...Berkeley -- Fossils discovered in the oft-painted ...time that dinosaurs and their non-dinosaur ancesto...s, disproving the notion that dinosaurs rapidly re...The fossils were excavated from the Hayden Quarry ...

NEW YORK (July 17, 2007) -- Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill

...The QCTN Biotech Rising Star Award is intended to ...ed as...having the potential to make significant c...dustry or research...sector Queenslands Rising St... said it is important to acknowledge the achieveme...

This release is also available in Spanish. ... This international collaboration has been the largest ever to have taken place in a large scale study on genetic differences between patients infected by

Rise of dinosaurs in Late Triassic more gradual than once thought 2 Rise of dinosaurs in Late Triassic more gradual than once thought 3 Rise of dinosaurs in Late Triassic more gradual than once thought 4 'Preconditioning' helps protect brain's blood vessels from stroke 2 'Preconditioning' helps protect brain's blood vessels from stroke 3 Awards celebrating women and biotech brilliance 2 Identified main genetic variants involved in response to HIV 2

Rise of dinosaurs in Late Triassic more gradual than once thought 'Preconditioning' helps protect brain's blood vessels from stroke Awards celebrating women and biotech brilliance Identified main genetic variants involved in response to HIV

... or a bowl of...bran cereal, you're likely to get ...ers now have a better idea why.......A UC Davis st...of Clinical Nutrition, indicates that increased fi...s in women and increases...levels of a certain hor...

...make Kansas a better place for llamas and alpacas....sor of anatomy and physiology said there are rough... States and it is difficult to find sufficient dru...s are concerned, they aren't even a blip on the ma...

Dec. 5 and 6, Thursday and Friday -- Experts from France...and the U.S. will discuss diseases such as smallpox,...influenza, Ebola virus and plague, and how these threats can...be countered, at a two

...XiGENE, Inc. (Nasdaq: OXGN, SSE: OXGN), in a step ...esearch of its lead vascular...targeting compound,......the signing of a funded research agreement with...ndation is a nationwide charitable...organization ...

Increased fiber curbs appetite in women 2 OXiGENE, foundation fighting blindness sign research agreement for phase I/II clinical trial 2 OXiGENE, foundation fighting blindness sign research agreement for phase I/II clinical trial 3

Increased fiber curbs appetite in women K-State professor studies medications available for llamas, alpacas Symposium on emerging diseases and bioterrorism OXiGENE, foundation fighting blindness sign research agreement for phase I/II clinical trial